Searchable abstracts of presentations at key conferences on calcified tissues

ba0004oc19 | (1) | ICCBH2015

The VINE study: vitamin D in newborns: a randomized controlled trial comparing daily and bolus supplementation in breastfed infants of vitamin D deficient mothers

Huynh Julie , Lu Thao , Liew Danny , Doery James , Tudball Ronald , Jona Madeleine , Bhamjee Roisin , Rodda Christine

Objective: There is no published data to demonstrate the efficacy and safety of a single bolus dose vitamin D in breastfed infants of vitamin D deficient mothers. We evaluated the efficacy and safety of this alternative approach in newborn infants <4 months of age.Method: This single centre study was conducted from Aug 2013 to May 2014. Of 307 pregnant women diagnosed with vitamin D deficiency (25OHD<50 nmol/l) 70 were recruited. Their newborn in...

ba0001oc3.1 | Osteoporosis pathophysiology and genetics | ECTS2013

Heavy cannabis use negatively impacts on bone density: a population based prospective study

Sophocleous Antonia , McKenzie James , Robertson Roy , Ralston Stuart H

The endocannabinoid system has important effects on bone mass and bone turnover. Mice with targeted inactivation of type 1 (CB1) and type 2 (CB2) cannabinoid receptors develop osteoporosis with increasing age raising the possibility that cannabinoid receptor agonists might protect against age-related bone loss. Since cannabis is the most widely used illegal drug and its main psychotropic component -Δ9-tetrahydrocannabinol (THC)- is an agonist at CB1 and CB2 receptors, we ...

ba0002p104 | (1) | ICCBH2013

Immunohistochemical localization of bone morphogenetic proteins and their receptors in human osteochondromas

Cuellar Araceli , Inui Atsuyuki , James Michelle , Reddi A Hari

Objectives: To define the role of bone morphogenetic proteins (BMP) in human osteochondromas. The expression of bone morphogenetic proteins and their corresponding receptors has not been clarified in osteochondromas. We determined immunohistochemically the localization and distribution of bone morphogenetic proteins 2, 4, 6 and 7, bone morphogenetic protein receptor types 1A, 1B and 2 and the functional effectors phosphorylated Smad proteins 1, 5 and 8 in the cartilaginous cap...

ba0006p030 | (1) | ICCBH2017

Outcomes of zoledronic acid use in paediatric conditions

Lim Angelina , Simm Peter , James Simon , Zacharin Margaret

Objectives: Intravenous bisphosphonates have been used in children for various primary and secondary bone fragility disorders for three decades but beyond osteogenesis imperfecta, there is very limited information published in relation to outcomes. We report the experience at the Royal Children’s Hospital (RCH), Melbourne using Zoledronic acid (ZA), describing outcomes based on the underlying condition for which treatment was given, with the aim of informing future protoc...

ba0007p129 | (1) | ICCBH2019

A smartphone-based survey of frequency and severity of adverse effects following bisphosphonate therapy in a Tertiary Paediatric Centre

Blackburn James , Price Victoria , Ramakrishnan Renuka , Dharmaraj Poonam

Objectives: The primary objective of this project was to determine the nature and timing of perceived early adverse effects associated with bisphosphonate therapy. Additional information was sought on how this affected the child and family, to determine if changes should be made to local guidelines.Methods: A Smartphone-based text message survey was sent to parents of patients receiving intravenous bisphosphonate therapy for primary and secondary osteopo...

ba0001pp235 | Cell biology: osteoclasts and bone resorption | ECTS2013

Differential effects of nitrogen-containing bisphosphonates on human PBMCs and MUTZ-3 cells

Kwaasi Aaron , Mabilleau Guillaume , Dunford James , Ebetino Frank , Zarei Ali , Pazianas Michael , Sabokbar Afsie , Russell Graham

Introduction: Nitrogen-containing bisphosphonates (N-BPs) can inhibit the differentiation and function of osteoclasts derived from Peripheral Blood Mononuclear cells (PBMCs) in a dose-dependent manner. MUTZ-3 cells are a potentially useful human cell line for studying osteoclast differentiation. The aim of this study was to elucidate the action of N-BPs on MUTZ-3 cells.Methods: Human PBMCs and MUTZ-3 cells were cultured in α-MEM supplemented with he...

ba0003oc1.5 | Phosphate metabolism, fracture repair and osteoarthritis | ECTS2014

The role of alarmins in fracture repair

Santo Ana Isabel Espirito , Chan James K. , Horwood Nicole J. , Nanchahal Jagdeep

Fractures are very common and affect 2% of the population per annum. Fragility fractures represent the greatest unmet need and are associated with high rates of morbidity and mortality. Currently, there is no approved therapy for enhancing healing of fragility fractures. We previously reported that upregulation of the early inflammatory response following skeletal injury can promote fracture repair (Glass et al PNAS 2011). Inflammation represents the earliest response followin...

ba0003pp299 | Osteoporosis: treatment | ECTS2014

Association between allopurinol use and hip fracture in older patients discharged from rehabilitation

Basu Ujani , Goodbrand James , McMurdo Marion , Donnan Peter , McGilchrist Mark , Frost Helen , George Jacob , Witham Miles

Background: Allopurinol reduces oxidative stress and interacts with purinergic signalling systems important in bone metabolism and muscle function. We assessed whether allopurinol use was associated with a reduced incidence of hip fracture in older people who had undergone rehabilitation.Methods: Analysis of prospective, routinely-collected rehabilitation and hospitalisation data. Data on patients discharged from a single inpatient geriatric rehabilitati...

ba0005oc6.6 | Development and differentiation (or Aging) | ECTS2016

Loss of the longevity gene SirT1 dysregulates chondrocytes and leads to an arthritic phenotype in vivo, via impaired autophagy

Sacitharan Pradeep Kumar , Zarebska Jadwiga , Gharios George Bou , Vincent Tonia , Edwards James

Ageing is universally linked to skeletal deterioration. Common mechanisms may control both processes, where dysregulation may predispose to bone loss and osteoarthritis (OA). The epigenetic modifier SirT1 controls lifespan and decreases with age. However, the role of SirT1 in joint disease is unclear. Human tissue samples, novel genetically modified mice, a surgical disease model and advanced cellular and molecular studies were employed to explore the hypothesis that SirT1 is ...